Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-25 @ 2:03 AM
NCT ID:
NCT03752060
Eligibility Criteria:
Inclusion Criteria:
* provide written and dated informed consent to participate in the study; (2) be willing and able to comply with the protocol
* be willing and able to comply with the protocol
* be a female between the ages of 45 and 65, inclusive
* be postmenopausal for ≥ 1 year
* be in good health and free from chronic cardiovascular, pulmonary, or musculoskeletal disease as determined by a health history questionnaire
* have a BMI between 18.5 and 40.0, inclusive; and
* answer no to all questions on the PAR-Q for people aged 15 to 69, which are as follows:
1. Has your doctor ever said that you have a heart condition and that you should only do physical activity recommended by a doctor?
2. Do you feel pain in your chest when you do physical activity?
3. In the past month, have you had chest pain when you were not doing physical activity?
4. Do you lose your balance because of dizziness or do you ever lose consciousness?
5. Do you have a bone or joint problem that could be made worse by a change in physical activity?
6. Is your doctor currently prescribing drugs for your blood pressure or heart condition? Do you know of any other reason why you should not do physical activity?
Exclusion Criteria:
* are currently prescribed and/or taking lipid-lowering medications
* are participating in another clinical trial within thirty days prior to enrollment
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
45 Years
Maximum Age:
65 Years
Study:
NCT03752060
Study Brief:
Protocol Section:
NCT03752060